The current valuation score of Molecular Partners AG is 7.84, ranking 192 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.96, which is -198.45% below the recent high of 1.93 and -183.86% above the recent low of -5.58.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.